{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:25:54Z","timestamp":1758633954661},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1994,2]]},"DOI":"10.1007\/bf01277594","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T06:25:37Z","timestamp":1111645537000},"page":"57-67","source":"Crossref","is-referenced-by-count":34,"title":["Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats"],"prefix":"10.1007","volume":"98","author":[{"given":"G.","family":"Skuza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Rogoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Quack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Danysz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01253131","volume":"36","author":"W Birkmayer","year":"1975","unstructured":"Birkmayer W, Riederer P, Youdim MBH, Linauer W (1975) The potentiation of the antiakinetic effect after L-DOPA treatment by an inhibitor of MAO-B, deprenyl. J Neural Transm 36: 303?326","journal-title":"J Neural Transm"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","volume":"13","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A (1990) Interaction between glutamatergic and monoaminergic systems within the basal ganglia ? implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272?276","journal-title":"Trends Neurosci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","volume":"12","author":"HSV Chen","year":"1992","unstructured":"Chen HSV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine ? therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12: 4427?4436","journal-title":"J Neurosci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410260518","volume":"26","author":"G Cohen","year":"1989","unstructured":"Cohen G, Spina MB (1989) Deprenyl suppresses the axidant stress associated with increased dopamine turnover. Ann Neurol 26: 689?690","journal-title":"Ann Neurol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2165\/00002512-199202020-00005","volume":"2","author":"RJ Coleman","year":"1992","unstructured":"Coleman RJ (1992) Current drug therapy for Parkinson's disease. A review. Drugs Aging 2: 112?124","journal-title":"Drugs Aging"},{"key":"CR6","doi-asserted-by":"crossref","unstructured":"Danysz W, Gossel M, Zajaczkowski W, Dill D, Quack G (1994) Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? Case of amantadine and memantine. J Neural Transm [PD Sect] (in press)","DOI":"10.1007\/BF02253435"},{"key":"CR7","first-page":"102","volume-title":"Parkinson's disease: from basic research to treatment","author":"G DiChiara","year":"1993","unstructured":"DiChiara G, Morelli M (1993) Dopamine acetylcholine glutamate interactions in the striaturn ? a working hypothesis. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Parkinson's disease: from basic research to treatment. Raven Press, New York, pp 102?106"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1600-0404.1973.tb01296.x","volume":"49","author":"C Feiling","year":"1973","unstructured":"Feiling C (1973) The effect of adding amantadine to optimum L-DOPA dosage in Parkinson's syndrome. Acta Neurol Scand 49: 245?251","journal-title":"Acta Neurol Scand"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02257618","volume":"4","author":"P Goodwin","year":"1992","unstructured":"Goodwin P, Starr BS, Starr MS (1992) Motor responses to dopamine-Dl and dopamine-D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK-801. J Neural Transm [PD Sect] 4: 15?26","journal-title":"J Neural Transm [PD Sect]"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archneur.1991.00530210109030","volume":"48","author":"JT Greenamyre","year":"1991","unstructured":"Greenamyre JT, O'Brien CF (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch Neurol 48: 977?981","journal-title":"Arch Neurol"},{"key":"CR11","first-page":"21","volume":"320","author":"R Jackisch","year":"1992","unstructured":"Jackisch R, Link T, Neufang B, Koch R (1992) Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine ? no evidence for direct dopaminomimetic or antimuscarinic properties. Arch Int Pharmacodyn Ther 320: 21?42","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410280411","volume":"28","author":"T Klockgether","year":"1990","unstructured":"Klockgether T, Turski L (1990) NMDA antagonists potentiate antiparkinsonian action of L-DOPA in monoamine-depleted rats. Ann Neurol 28: 539?546","journal-title":"Ann Neurol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/med.2610120504","volume":"12","author":"J Knoll","year":"1992","unstructured":"Knoll J (1992) Pharmacological basis of the therapeutic effect of (?)deprenyl in age-related neurological diseases. Med Res Rev 12: 505?524","journal-title":"Med Res Rev"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0922-4106(91)90113-V","volume":"206","author":"J Kornhuber","year":"1991","unstructured":"Kornhuber J, Bormann J, Hubers M, Rusche K, Riederer P (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel ? a human postmortem brain study. Eur J Pharmacol ? Mol Pharmacol Sect 206: 297?300","journal-title":"Eur J Pharmacol ? Mol Pharmacol Sect"},{"key":"CR15","first-page":"91","volume":"43","author":"J Kornhuber","year":"1994","unstructured":"Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Aman tadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm [Suppl] 43: 91?104","journal-title":"J Neural Transm [Suppl]"},{"key":"CR16","first-page":"717","volume":"263","author":"A Lupp","year":"1992","unstructured":"Lupp A, Lucking CH, Koch R, Jackisch R, Feuerstein TJ (1992) Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro. J Pharmacol Exp Ther 263: 717?724","journal-title":"J Pharmacol Exp Ther"},{"key":"CR17","first-page":"349","volume":"45","author":"J Maj","year":"1993","unstructured":"Maj J, Skuza G, Rogoz Z (1993 a) Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists in mice. Pol J Pharmacol 45: 349?360","journal-title":"Pol J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02252623","volume":"6","author":"J Maj","year":"1993","unstructured":"Maj J, Skuza G, Rogoz Z (1993 b) Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J Neural Transm [PD Sect] 6: 53?62","journal-title":"J Neural Transm [PD Sect]"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0149-7634(88)80046-0","volume":"12","author":"FS Messiha","year":"1988","unstructured":"Messiha FS (1988) Effect of amantadine on chlorpromazine and reserpine-induced behavioral depression in the mouse. Neurosci Biobehav Rev 12: 219?222","journal-title":"Neurosci Biobehav Rev"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2165\/00003495-199346030-00005","volume":"46","author":"JL Montastruc","year":"1993","unstructured":"Montastruc JL, Rascol O, Senard JM (1993) Current status of dopamine agonists in Parkinson's disease management. Drugs 46: 384?393","journal-title":"Drugs"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"261S","DOI":"10.1016\/0197-0186(92)90249-Q","volume":"20","author":"M Morelli","year":"1992","unstructured":"Morelli M, Febu S, DiChiara G (1992) Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-l and D-2 receptors. Neurochem Int 20 [Suppl]: 261S-264S","journal-title":"Neurochem Int"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-4886(90)90134-E","volume":"108","author":"J Olney","year":"1990","unstructured":"Olney J, Zorumski C, Stewart G, Price M, Wang G, Labruyere J (1990) Excitotoxicity of L-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's diseases. Exp Neurol 108: 269?272","journal-title":"Exp Neurol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02260076","volume":"4","author":"JM Rabey","year":"1992","unstructured":"Rabey JM, Nissipeanu P, Korczyn AD (1992) Efficacy of memantine, and NMDA receptor antagonist, in the treatment of Parkinson's disease. J Neural Transm [PD Sect] 4: 277?282","journal-title":"J Neural Transm [PD Sect]"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ddr.430290309","volume":"29","author":"P Rojas","year":"1993","unstructured":"Rojas P, Altagracia M, Kravzov J, Rios C (1993) Amantadine increases striatal dopamine turnover in MPTP-treated mice. Drug Dev Res 29: 222?226","journal-title":"Drug Dev Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(89)90007-5","volume":"32","author":"WJ Schmidt","year":"1989","unstructured":"Schmidt WJ, Bubser M (1989) Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats. Pharmacol Biochem Behav 32: 621?623","journal-title":"Pharmacol Biochem Behav"},{"key":"CR26","first-page":"65","volume":"38","author":"WJ Schmidt","year":"1992","unstructured":"Schmidt WJ, Bubser M, Hauber W (1992) Behavioral pharmacology of glutamate in the basal ganglia. J Neural Transm [Suppl] 38: 65?89","journal-title":"J Neural Transm [Suppl]"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000116869","volume":"32","author":"I Shoulson","year":"1992","unstructured":"Shoulson I (1992) An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. Eur Neurol 32: 46?53","journal-title":"Eur Neurol"},{"key":"CR28","first-page":"50","volume":"235","author":"LD Snell","year":"1985","unstructured":"Snell LD, Johnson KM (1985) Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J Pharmacol Exp Ther 235: 50?57","journal-title":"J Pharmacol Exp Ther"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.2563176","volume":"243","author":"PK Somalia","year":"1989","unstructured":"Somalia PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398?400","journal-title":"Science"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0014-2999(92)90634-G","volume":"213","author":"JC Stoof","year":"1992","unstructured":"Stoof JC, Booij J, Drukarch B, Wolters EC (1992) The anti-Parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way. Eur J Pharmacol 213: 439?443","journal-title":"Eur J Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01250961","volume":"90","author":"A Svensson","year":"1992","unstructured":"Svensson A, Carlsson A, Carlsson ML (1992) Differential locomotor interactions between dopamine D-l\/D-2 receptor agonists and the NMDA antagonist dizocilpine in mono-amine-depleted mice. J Neural Transm [Gen Sect] 90: 199?217","journal-title":"J Neural Transm [Gen Sect]"},{"key":"CR32","first-page":"1","volume-title":"Progress in medicinal chemistry, vol 18","author":"JW Tilley","year":"1981","unstructured":"Tilley JW, Kramer MJ (1981) Amantadine derivatives. In: Ellis GP, West GB (eds) Progress in medicinal chemistry, vol 18. Elsevier, Amsterdam, pp 1?44"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","volume":"349","author":"L Turski","year":"1991","unstructured":"Turski L, Bressler K, Rettig KJ, Loschmann PA, Wachtel H (1991) Protection of substantianigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349: 414?417","journal-title":"Nature"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01277594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01277594\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01277594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T18:10:41Z","timestamp":1556647841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01277594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["BF01277594"],"URL":"https:\/\/doi.org\/10.1007\/bf01277594","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}